Intelligent Bio Solutions Inc. Market Cap ($5.07 Million)
Market Cap & Net Worth: Intelligent Bio Solutions Inc. (INBS)
Intelligent Bio Solutions Inc. market cap. Intelligent Bio Solutions Inc. (NASDAQ:INBS) has a market capitalization of $5.07 Million ($5.07 Million) as of November 4, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #28486 globally and #5865 in its home market, demonstrating a 7.93% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Intelligent Bio Solutions Inc.'s stock price $1.77 by its total outstanding shares 3316803 (3.32 Million). Also see Intelligent Bio Solutions Inc. cash conversion from operations for how efficiently the company converts equity into cash flow.
Intelligent Bio Solutions Inc. Market Cap History (2020–2026)
Intelligent Bio Solutions Inc. market cap history from 2020 to 2026. Data shows change from $5.89 Billion to $5.87 Million (-71.24% CAGR). Check INBS stock price for real-time trading data and today's change.
Index Memberships
Intelligent Bio Solutions Inc. is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NASDAQ Health Care
IXHC
|
$2.61 Trillion | 0.00% | #814 of 976 |
|
NASDAQ Composite
IXIC
|
$40.20 Trillion | 0.00% | #2616 of 3165 |
Weight: Intelligent Bio Solutions Inc.'s market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Intelligent Bio Solutions Inc. Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Intelligent Bio Solutions Inc.'s valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore how fast is Intelligent Bio Solutions Inc. growing its equity to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
1.39x
Intelligent Bio Solutions Inc.'s market cap is 1.39 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2020 | $5.89 Billion | $188.74K | -$3.71 Million | 31209.69x | N/A |
| 2021 | $1.14 Billion | $1.98 Million | -$7.04 Million | 576.78x | N/A |
| 2023 | $13.45 Million | $1.26 Million | -$10.63 Million | 10.70x | N/A |
| 2024 | $4.64 Million | $3.11 Million | -$10.16 Million | 1.49x | N/A |
| 2025 | $31.61 Million | $3.05 Million | -$10.57 Million | 10.36x | N/A |
| 2026 | $5.87 Million | $4.22 Million | -$12.43 Million | 1.39x | N/A |
Competitor Companies of INBS by Market Capitalization
Companies near Intelligent Bio Solutions Inc. in the global market cap rankings as of November 4, 2026. Also see total assets of Intelligent Bio Solutions Inc. for a full breakdown of the balance sheet.
Key companies related to Intelligent Bio Solutions Inc. by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #110 globally with a market cap of $190.23 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #204 globally with a market cap of $119.12 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #226 globally with a market cap of $109.30 Billion USD.
- Medtronic plc (SA:MDTC34): Ranked #239 globally with a market cap of $104.84 Billion USD ( R$534.32 Billion BRL).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #110 | Abbott Laboratories | NYSE:ABT | $190.23 Billion | $109.40 |
| #204 | Stryker Corporation | NYSE:SYK | $119.12 Billion | $310.55 |
| #226 | Medtronic PLC | NYSE:MDT | $109.30 Billion | $98.88 |
| #239 | Medtronic plc | SA:MDTC34 | $104.84 Billion | R$208.39 |
Market Capitalization of Intelligent Bio Solutions Inc. (2020–2026)
Market capitalization of Intelligent Bio Solutions Inc. from 2020 to today. Between 2020 and today, Intelligent Bio Solutions Inc.'s market cap moved from $5.89 Billion to $ 5.87 Million, with a yearly change of -71.24%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $5.87 Million | -81.43% |
| 2025 | $31.61 Million | +580.71% |
| 2024 | $4.64 Million | -65.48% |
| 2023 | $13.45 Million | -91.55% |
| 2022 | $159.21 Million | -86.06% |
| 2021 | $1.14 Billion | -80.61% |
| 2020 | $5.89 Billion | -- |
End of Day Market Cap According to Different Sources
On Nov 4th, 2026 the market cap of Intelligent Bio Solutions Inc. was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $5.07 Million USD |
| MoneyControl | $5.07 Million USD |
| MarketWatch | $5.07 Million USD |
| marketcap.company | $5.07 Million USD |
| Reuters | $5.07 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Intelligent Bio Solutions Inc.
Intelligent Bio Solutions Inc., a medical technology company, focused on developing and delivering non-invasive testing, and screening solutions in Asia Pacific, the United States, the United Kingdom, and internationally. The company operates intelligent fingerprinting drug screening system, a platform to analyze fingerprint sweat analysis to detect drugs abuse; and biosensor platform. The compan… Read more